Newsletter | April 23, 2025

04.23.25 -- Enhancing Precision & Efficiency In Gene Editing Research

SAFER Detection™ For Efficient Interrogation Of DNA Rearrangements

Discover SAFER Detection, an advanced NGS method identifying DNA rearrangements in gene-edited cells. Ensure the integrity of your edits with this efficient tool for analyzing potential structural changes caused by gene editing.

 

Enabling The Development And Rapid, Reproducible Manufacturing Of TranspoCART Cells

Accelerate cell therapy development with technology that streamlines TranspoCART™ cell production. Learn how this innovation enables faster, more consistent manufacturing, bringing potentially life-saving therapies to patients sooner.

 

Allogeneic CAR T Cells As A Potential Therapy For Acute Myeloid Leukemia

Uncover the promise of allogeneic CAR T-cells for AML. Breakthroughs in development could offer a readily available, "off-the-shelf" cell therapy approach, providing new hope for treating acute myeloid leukemia.

 

Overcome The Limitations Of Conventional Transfection With Electroporation

Learn how electroporation technology outperforms traditional methods in this informative webinar. Peter Gee, Ph.D., details how electroporation improves gene editing efficiency, reduces cell death, and enables scalable workflows for cell therapy, screening, and bioproduction.

 

Variant-Aware Therapeutic Guide Selection

Achieve safer therapeutic gene editing. Learn about a technology that selects precise CRISPR guide RNAs by analyzing genetic diversity across thousands of genomes, significantly minimizing harmful off-target effects in diverse populations.

 

SOLUTIONS

On-Target And Off-Target Assessment Assays

De-risk gene therapy development with a comprehensive assessment platform. Integrated assays provide unparalleled precision in guide RNA selection and off-target analysis, meeting safety standards and accelerating your path to the clinic.

• Request Information

 

 

 

On- And Off-Target Gene Editing Assessment Services

Prioritize patient safety with SeQure Dx's expert off-target analysis. Our specialized services use advanced assays to thoroughly assess risk and confirm editing precision, improving the safety profile of your gene therapies.

• Request Information